Open Innovation: Transforming the Model of Biopharmaceutical R&D

Gender diversity and equality in leadership positions have been shown to improve profitability and return on equity through greater innovation and more creative solutions.

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

The value of outsourcing partnerships for next-gen biotherapeutics rests in the expertise and technologies that service providers bring to the table.

Learn Morewww.bio-rad.com/fluvaccine

The company plans to assess alternate payloads for its gene therapy program, which will shift its timeline.

Personalized medicine is a trend that continues to impact innovation and business decisions in the biopharma industry.